BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28660295)

  • 41. Prostate MR Imaging: An Update.
    Shaish H; Taneja SS; Rosenkrantz AB
    Radiol Clin North Am; 2017 Mar; 55(2):303-320. PubMed ID: 28126217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
    Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
    Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.
    Osses DF; van Asten JJ; Kieft GJ; Tijsterman JD
    World J Urol; 2017 Feb; 35(2):207-212. PubMed ID: 27287889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.
    de Gorski A; Rouprêt M; Peyronnet B; Le Cossec C; Granger B; Comperat E; Cussenot O; Renard-Penna R; Mozer P
    J Urol; 2015 Sep; 194(3):669-73. PubMed ID: 25784374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledge.
    Dinh CV; Steenbergen P; Ghobadi G; van der Poel H; Heijmink SW; de Jong J; Isebaert S; Haustermans K; Lerut E; Oyen R; Ou Y; Christos D; van der Heide UA
    Med Phys; 2017 Mar; 44(3):949-961. PubMed ID: 28039927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate MRI based on PI-RADS version 2: how we review and report.
    Steiger P; Thoeny HC
    Cancer Imaging; 2016 Apr; 16():9. PubMed ID: 27067275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate magnetic resonance imaging: The truth lies in the eye of the beholder.
    Riney JC; Sarwani NE; Siddique S; Raman JD
    Urol Oncol; 2018 Apr; 36(4):159.e1-159.e5. PubMed ID: 29336979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer].
    Tawadros T; Burruni R; Herrera F; Codeluppi C; Zurkinden C; Meuwly JY; Lhermitte B; Berthold D
    Rev Med Suisse; 2013 Dec; 9(409):2270-2, 2274. PubMed ID: 24416882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiparametric prostate MRI: technical conduct, standardized report and clinical use.
    Manfredi M; Mele F; Garrou D; Walz J; Fütterer JJ; Russo F; Vassallo L; Villers A; Emberton M; Valerio M
    Minerva Urol Nefrol; 2018 Feb; 70(1):9-21. PubMed ID: 28494579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer.
    Rhee H; Thomas P; Shepherd B; Gustafson S; Vela I; Russell PJ; Nelson C; Chung E; Wood G; Malone G; Wood S; Heathcote P
    J Urol; 2016 Oct; 196(4):1261-7. PubMed ID: 27220897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incorporating imaging into personalized medicine for the detection of prostate cancer: Pharmacological research-Urogenital pharmacology.
    Mertan F; Turkbey B
    Pharmacol Res; 2016 Dec; 114():163-165. PubMed ID: 27777131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
    Tay KJ; Mendez M; Moul JW; Polascik TJ
    Curr Opin Urol; 2015 May; 25(3):185-90. PubMed ID: 25768694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of transrectal ultrasonography in prostate cancer.
    Ghai S; Toi A
    Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.
    Jia JB; Houshyar R; Verma S; Uchio E; Lall C
    Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?
    Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Bollito E; Papotti M; Molineris I; Passera R; Regge D
    J Urol; 2014 Jul; 192(1):60-6. PubMed ID: 24518780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.